We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Evacetrapib in High-Risk Vascular Disease (ACCELERATE)

This study has been terminated.
(Study termination due to insufficient efficacy.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01687998
First Posted: September 19, 2012
Last Update Posted: December 13, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
The Cleveland Clinic
Information provided by (Responsible Party):
Eli Lilly and Company
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: August 13, 2016
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):